American Century Companies Inc. Buys 4,153 Shares of U.S. Physical Therapy, Inc. $USPH

Key Points

• American Century Companies Inc. increased its holdings in U.S. Physical Therapy by 45.9% in the first quarter, owning about 0.09% of the company worth $955,000.
• U.S. Physical Therapy reported a 0.81 EPS for the quarter, exceeding analysts' estimates and showcasing a 18.0% year-over-year revenue growth.
• The company announced a quarterly dividend of $0.45 per share, indicating an annual yield of 2.2% with a payout ratio of 78.60%.

American Century Companies Inc. lifted its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 45.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 13,204 shares of the company's stock after acquiring an additional 4,153 shares during the quarter. American Century Companies Inc. owned approximately 0.09% of U.S. Physical Therapy worth $955,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of U.S. Physical Therapy by 952.4% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock worth $32,000 after buying an additional 400 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new stake in U.S. Physical Therapy during the 4th quarter valued at about $39,000. Fifth Third Bancorp boosted its holdings in U.S. Physical Therapy by 34.6% in the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock valued at $75,000 after purchasing an additional 265 shares during the last quarter. Lazard Asset Management LLC acquired a new position in shares of U.S. Physical Therapy in the 4th quarter worth approximately $84,000. Finally, First Horizon Advisors Inc. lifted its holdings in U.S. Physical Therapy by 35.0% during the 1st quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company's stock worth $140,000 after buying an additional 500 shares in the last quarter.

U.S. Physical Therapy Trading Down 1.1%

Shares of U.S. Physical Therapy stock traded down $0.97 during trading hours on Tuesday, hitting $83.83. The company's stock had a trading volume of 14,326 shares, compared to its average volume of 142,222. The company has a market capitalization of $1.27 billion, a PE ratio of 36.54, a P/E/G ratio of 4.29 and a beta of 1.47. The business has a fifty day moving average of $79.92 and a 200 day moving average of $76.57. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The business had revenue of $197.34 million during the quarter, compared to the consensus estimate of $190.24 million. During the same period in the prior year, the firm earned $0.73 earnings per share. The business's quarterly revenue was up 18.0% compared to the same quarter last year. As a group, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be issued a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Friday, August 22nd. U.S. Physical Therapy's dividend payout ratio (DPR) is 78.60%.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Zacks Research raised shares of U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. Barrington Research raised their price objective on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an "outperform" rating in a research note on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $110.25.

Insider Activity

In other news, CFO Carey P. Hendrickson sold 698 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $86.11, for a total value of $60,104.78. Following the transaction, the chief financial officer directly owned 27,808 shares of the company's stock, valued at $2,394,546.88. This trade represents a 2.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Graham D. Reeve sold 1,792 shares of the firm's stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $86.57, for a total transaction of $155,133.44. Following the sale, the chief operating officer owned 22,246 shares of the company's stock, valued at approximately $1,925,836.22. This represents a 7.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,653 shares of company stock worth $563,584 in the last 90 days. 2.00% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.